首页> 外文期刊>Therapeutic advances in psychopharmacology. >Effectiveness of paliperidone depot injection in seriously violent men with comorbid schizophrenia and dissocial personality disorder in a UK high-security hospital
【24h】

Effectiveness of paliperidone depot injection in seriously violent men with comorbid schizophrenia and dissocial personality disorder in a UK high-security hospital

机译:在英国一家高安全性医院中,帕潘立酮储库注射液对严重暴力合并精神分裂症和社交性人格障碍的男性有效

获取原文
           

摘要

High-security hospital patients are often complex in presentation and are characterized by treatment resistance, medication nonadherence and history of violence. Paliperidone is licensed both as an oral and depot antipsychotic medication in the treatment of schizophrenia. Clinical trials have shown that paliperidone depot is well tolerated with similar efficacy to risperidone depot but with additional practical advantages. Whilst data exist for the effectiveness of paliperidone palmitate (PP), there are no studies involving patients in forensic settings or those with comorbid personality disorder. Our aim was to evaluate the effectiveness of PP on violence, aggression and personality disorder symptoms. This project was a retrospective service evaluation involving 11 patients, carried out in a high-security hospital. A combination of patient records and interviews with the treating consultant psychiatrist were used to ascertain a Clinical Global Impression (CGI) score, the effect of PP on specific personality disorder symptom domains (cognitive-perceptual, impulsive-behavioural dyscontrol and affective dysregulation) and incidents of violence and aggression. Engagement with occupational and psychological therapies was also evaluated. Metabolic parameters were reviewed. A total of 6 out of 11 patients continued on PP, most of whom had schizophrenia and dissocial personality disorder with histories of violence. All showed improvement in the CGI score with associated benefits in the three personality symptom domains. Overall, two patients demonstrated a reduction in the risk of violence. There was improvement in engagement with occupational therapy and psychological work. No significant effects on metabolic parameters were noted although hyperprolactinaemia, albeit asymptomatic, was consistently recorded. This pragmatic service evaluation of a small but complex patient group demonstrated, for the first time, that PP was effective in reducing violence as well as improving personality pathology across all dimensions: a finding which could have significant implications for management of such high-security patients.
机译:高安全性医院患者的表现通常很复杂,其特征在于治疗抵抗,药物不依从和暴力史。 Paliperidone被许可作为精神分裂症的口服和长效抗精神病药物。临床试验表明,帕潘立酮贮库具有良好的耐受性,其功效与利培酮贮库相似,但具有更多的实际优势。尽管存在帕潘立酮棕榈酸酯(PP)有效性的数据,但尚无涉及法医患者或合并性人格障碍患者的研究。我们的目的是评估PP对暴力,侵略和人格障碍症状的有效性。该项目是在高安全性医院进行的一项回顾性服务评估,涉及11名患者。通过结合患者记录和对治疗顾问精神病医生的访谈来确定临床总体印象(CGI)评分,PP对特定人格障碍症状域(认知-感知,冲动-行为失控和情感失调)的影响暴力和侵略。对职业和心理疗法的参与度也进行了评估。审查了代谢参数。 11例患者中共有6例继续使用PP,其中大多数患有精神分裂症和社交性人格障碍,有暴力史。在三个人格症状域中,所有患者均显示CGI评分得到改善,并具有相关益处。总体而言,两名患者的暴力风险有所降低。参与职业治疗和心理工作的情况有所改善。尽管持续记录了高催乳激素血症,尽管无症状,但对代谢参数没有显着影响。这项对一个小而复杂的患者群体的务实服务评估首次表明,PP在减少暴力以及改善各个方面的人格病变方面均有效:这一发现可能对此类高安全性患者的治疗产生重大影响。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号